236 related articles for article (PubMed ID: 11082412)
21. Preischemic bradykinin and ischaemic preconditioning in functional recovery of the globally ischaemic rat heart.
Starkopf J; Bugge E; Ytrehus K
Cardiovasc Res; 1997 Jan; 33(1):63-70. PubMed ID: 9059529
[TBL] [Abstract][Full Text] [Related]
22. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
Barsotti A; Di Napoli P; Taccardi AA; Spina R; Stuppia L; Palka G; Barbacane RC; De Caterina R; Conti P
Atherosclerosis; 2001 Mar; 155(1):53-9. PubMed ID: 11223426
[TBL] [Abstract][Full Text] [Related]
23. Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2.
Maulik N; Engelman RM; Rousou JA; Flack JE; Deaton D; Das DK
Circulation; 1999 Nov; 100(19 Suppl):II369-75. PubMed ID: 10567332
[TBL] [Abstract][Full Text] [Related]
24. Bradykinin protects the rabbit heart after cardioplegic ischemia via NO-dependent pathways.
Feng J; Li H; Rosenkranz ER
Ann Thorac Surg; 2000 Dec; 70(6):2119-24. PubMed ID: 11156131
[TBL] [Abstract][Full Text] [Related]
25. Redox regulation of angiotensin II preconditioning of the myocardium requires MAP kinase signaling.
Das S; Otani H; Maulik N; Das DK
J Mol Cell Cardiol; 2006 Aug; 41(2):248-55. PubMed ID: 16697003
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
27. Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts.
Nuñez RE; Javadov S; Escobales N
Pflugers Arch; 2018 Sep; 470(9):1391-1403. PubMed ID: 29748710
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of the cardioprotective effect of inhibition of the renin-angiotensin system on ischemia/reperfusion-induced myocardial injury.
Wang LX; Ideishi M; Yahiro E; Urata H; Arakawa K; Saku K
Hypertens Res; 2001 Mar; 24(2):179-87. PubMed ID: 11325078
[TBL] [Abstract][Full Text] [Related]
29. Omapatrilat limits infarct size and lowers the threshold for induction of myocardial preconditioning through a bradykinin receptor-mediated mechanism.
Ebrahim Z; Baxter GF; Yellon DM
Cardiovasc Drugs Ther; 2004 Mar; 18(2):127-34. PubMed ID: 15162074
[TBL] [Abstract][Full Text] [Related]
30. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
Wang CH; Leung N; Lapointe N; Szeto L; Uffelman KD; Giacca A; Rouleau JL; Lewis GF
Circulation; 2003 Apr; 107(14):1923-9. PubMed ID: 12668518
[TBL] [Abstract][Full Text] [Related]
31. Effects of ACE inhibition on myocardial apoptosis in an ischemia-reperfusion rat heart model.
Kobara M; Tatsumi T; Kambayashi D; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Fushiki S; Nakagawa M
J Cardiovasc Pharmacol; 2003 Jun; 41(6):880-9. PubMed ID: 12775965
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
33. AT(1) and AT(2) receptor expression and blockade after acute ischemia-reperfusion in isolated working rat hearts.
Xu Y; Kumar D; Dyck JR; Ford WR; Clanachan AS; Lopaschuk GD; Jugdutt BI
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1206-15. PubMed ID: 11893553
[TBL] [Abstract][Full Text] [Related]
34. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart.
Morris SD; Yellon DM
J Am Coll Cardiol; 1997 Jun; 29(7):1599-606. PubMed ID: 9180125
[TBL] [Abstract][Full Text] [Related]
35. Effects of captopril and losartan on myocardial ischemia-reperfusion induced arrhythmias and necrosis in rats.
Ozer MK; Sahna E; Birincioglu M; Acet A
Pharmacol Res; 2002 Apr; 45(4):257-63. PubMed ID: 12030787
[TBL] [Abstract][Full Text] [Related]
36. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
[TBL] [Abstract][Full Text] [Related]
37. Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Takeda H; Haneda T; Kikuchi K
Jpn Circ J; 1997 Aug; 61(8):687-94. PubMed ID: 9276774
[TBL] [Abstract][Full Text] [Related]
38. Selective blockade of AT1 angiotensin II receptors abolishes ischemic preconditioning in isolated rabbit hearts.
Diaz RJ; Wilson GJ
J Mol Cell Cardiol; 1997 Jan; 29(1):129-39. PubMed ID: 9040028
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
40. Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts.
Yang BC; Phillips MI; Ambuehl PE; Shen LP; Mehta P; Mehta JL
Circulation; 1997 Aug; 96(3):922-6. PubMed ID: 9264502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
